Clinical studies have demonstrated a strong correlation between elevated CCR3 and ligand expression levels with disease severity in asthma patients, underscoring its therapeutic potential for eosinophil-mediated inflammatory disorders [23]. The gene discussed is CCR3; the disease is asthma.